A comparative clinical trial to evaluate efficacy and safety of the 308-nm excimer laser and the gain-switched 311-nm titanium:sapphire laser in the treatment of vitiligo.
Myeong Jin ParkUri SohnGi Hyun SeongMyung Hwa KimByung Cheol ParkSeung-Phil HongPublished in: Photodermatology, photoimmunology & photomedicine (2019)
The gain-switched 311-nm TSL exhibited similar efficacy to the 308-nm EL in treating vitiligo as well as improved safety. Therefore, the 311-nm TSL is considered as a candidate device to replace the EL as a new and promising treatment option for localized vitiligo.